Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Depreciation and Depletion (2017 - 2025)

HealthLynked (HLYK) has disclosed Depreciation and Depletion for 8 consecutive years, with $20155.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation and Depletion fell 27.15% to $20155.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $103853.0, a 11.91% decrease, with the full-year FY2024 number at $115102.0, down 7.08% from a year prior.
  • Depreciation and Depletion was $20155.0 for Q3 2025 at HealthLynked, down from $27238.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $31253.0 in Q2 2023 to a low of $20155.0 in Q3 2025.
  • A 5-year average of $28111.7 and a median of $28436.0 in 2024 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: surged 34.54% in 2023, then fell 27.15% in 2025.
  • HealthLynked's Depreciation and Depletion stood at $25291.0 in 2021, then fell by 8.23% to $23210.0 in 2022, then skyrocketed by 34.54% to $31226.0 in 2023, then fell by 8.93% to $28436.0 in 2024, then fell by 29.12% to $20155.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Depreciation and Depletion are $20155.0 (Q3 2025), $27238.0 (Q2 2025), and $28024.0 (Q1 2025).